Catalpa Ventures

Catalpa Ventures is an early-stage venture capital firm dedicated to investing in technology companies that are revolutionizing healthcare across Extended Europe, with a particular focus on the DACH region (Germany, Austria, Switzerland), Benelux, and emerging hubs. The firm's core mission is to improve the health of 100 million people by backing ambitious founders who leverage technology to address critical challenges within the healthcare sector. Their investment thesis is built around three major societal shifts: demographic inversion, which highlights the needs of an aging population; the escalating shortage of healthcare professionals; and the rapidly growing healthcare costs that are straining existing systems.

The firm was founded in 2024 by a team of seasoned professionals, including Dr. rer. pol. Thomas Goergen, Prof. Dr. med. Silke R. Sperling, and Dr.-Ing. Christian Goergen. This founding team brings diverse backgrounds in medicine, venture capital, and entrepreneurship, united by a shared conviction in the transformative potential of digital innovations to enhance health and well-being. Catalpa Ventures launched its first fund, Catalpa Health Fund I, with a target size of €30 million, securing initial commitments from entrepreneurs, family offices, and industry leaders.

Catalpa Ventures focuses on early-stage investments, typically ranging from Pre-Seed to Series A, with an initial ticket size between €300,000 and €1.5 million, and reserves for follow-on funding. Their portfolio includes innovative companies such as Noah Labs, which is developing vocal biomarkers for the early detection of cardiac decompensation, and Remi Health, a platform that enables seamless and compliant diagnostic testing within patient journeys for various healthcare stakeholders. These investments reflect the firm's commitment to supporting scalable, evidence-based solutions that strengthen clinical capacity and improve patient outcomes.

The investment team at Catalpa Ventures is comprised of experienced partners and principals, including the founding partners Dr. Thomas Goergen, Prof. Dr. Silke R. Sperling, and Dr. Christian Goergen, alongside Managing Partner Willibrord Ehses, Principal Adrian Goergen, Partner Daniel Kranz, and Principal Yemisi Toyosi. Their collective expertise spans business development, investor relations, and investment management, providing strategic support and guidance to their portfolio companies. The firm emphasizes digitalization as a key driver for both economic impact and socially sustainable progress in healthcare.